Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) would like to announce that it has an agreement in principle to sell its MindUp BioResearch division to a large modern herbal medicine company in China. The buyer, founded in 2004, focuses on production and manufacturing of premium herbs, herbal extracts and herbal preparations. Name of the buyer will be announced in a joint news announcement shortly, once all due diligence is completed (see also Hard to Treat Diseases).
MindUp BioResearch (mindupbioresearch.com) focuses on research of new therapeutics that would overcome the Cancer Cell Resistance in chemotherapy and also conducts research on identification of genes …
No comments:
Post a Comment